The worldwide skull clamp market size was esteemed at USD 222.39 million of every 2018 and is expected to show a CAGR of 4.7% over the conjecture period. Expanding occurrence of Traumatic Brain Injuries (TBIs) and Central Nervous System (CNS) and mind tumors is driving the development.
Skull clamp are clinical gadgets used to balance out the head during skull medical procedures. These gadgets are utilized as a holder to adjust the patient's head for better access while performing neurosurgeries. Skull clamp are utilized in different strategies like craniotomy for tumor evacuation; head injury wounds; cerebrovascular issues like aneurysms; and neurodegenerative problems like Parkinson's sickness or epilepsy.
Skull clamp are likewise utilized in clinical imaging advancements, like Magnetic Resonance Imaging (MRI), skull radiography, and Computed Tomography (CT) check. Moreover, rising commonness of cerebrum tumor and pediatric issues, for example, hydrocephalus are not many elements driving the skull clamp market development.
What's more, the expanding number of neurosurgeries attributable to developing head injury wounds, pediatric issues, and neurodegenerative infections are other few variables driving the general market development. As per the Center for Disease Control and Prevention (CDC), TBI is a significant reason for casualty in the U.S. since 2006, and its rate is expanding by 53% consistently.
According to the American Association of Neurosurgical Surgeons, in the U.S., 1.7 million of TBI cases are analyzed each year. As indicated by the AFFiRiS AG, because of Parkinson's infection 7-10 million individuals are experiencing hazardous handicaps, like loss of nerve cells in the cerebrum. Along these lines, an expanding number of TBI cases and patients experiencing neurodegenerative illnesses are expanding the interest for neurosurgeries subsequently driving the market development.